Omega Funds invests in life‑science companies developing breakthrough medicines across therapeutic areas such as oncology, immunology, rare diseases and precision medicine. They focus on exceptional founders and impactful platforms, providing capital from early seed through later‑stage rounds and public investments to bring innovative treatments to patients worldwide.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United Kingdom
33.3%United States of America
22.2%Switzerland
11.1%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Stage agnostic
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Omega Fund VIII
Vintage 2025 • $647.0M
Omega Fund VII
Vintage 2021 • $647.0M
Omega Fund VI
Vintage 2021 • $438.0M